About
Mistletoe Therapy
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
685
By Phase
PHASE3: 2PHASE4: 1PHASE1/PHASE2: 1
By Status
COMPLETED: 3ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT02106572Lead Sponsor
Therapeutic Instillation of Mistletoe
PHASE3Active, not recruiting
548 participants
Started: Apr 30, 2015 · Completed: Dec 31, 2028
NCT02191540Collaborator
Efficacy and Safety Study of Abnoba Viscum F 20mg in Malignant Pleural Effusion Patients
PHASE3Completed
68 participants
Started: Jan 31, 2011 · Completed: May 31, 2013
NCT01401075Lead Sponsor
RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patients
PHASE4Completed
32 participants
Started: Mar 31, 2006 · Completed: Apr 30, 2008
NCT02007005Lead Sponsor
Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer
PHASE1/PHASE2Completed
37 participants
Started: Jan 31, 2004 · Completed: Sep 30, 2013
Locations (1)
Headquarters
Niefern-Oeschelbronn, Germany
Map
Loading map...